Clinical Trial Update: Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of BMS-986142 on the pharmacokinetics of methotrexate and a probe substrate cocktail in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-986142
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED